| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHINTE.168.14.1514 |
| P8608 | Fatcat ID | release_pi2onhiatnd3jcxon2wwl2mqoy |
| P932 | PMC publication ID | 2694610 |
| P698 | PubMed publication ID | 18663163 |
| P5875 | ResearchGate publication ID | 23133768 |
| P50 | author | Douglas P. Kiel | Q46935730 |
| Sudha Seshadri | Q28516588 | ||
| Ramachandran S. Vasan | Q30348351 | ||
| Alexa Beiser | Q42561271 | ||
| Philip A Wolf | Q42561276 | ||
| Rhoda Au | Q43127298 | ||
| P2093 | author name string | Sanford Auerbach | |
| Zaldy S Tan | |||
| P2860 | cites work | Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death | Q46255669 |
| Longitudinal evidence of the impact of normal thyroid stimulating hormone variations on cognitive functioning in very old age. | Q46458206 | ||
| Thyroid hormones regulate beta-amyloid gene splicing and protein secretion in neuroblastoma cells | Q48024383 | ||
| Selective persistent reduction in choline acetyltransferase activity in basal forebrain of the rat after thyroid deficiency during early life | Q48204946 | ||
| Thyrotropin releasing hormone (TRH) in the hippocampus of Alzheimer patients. | Q48491990 | ||
| NS-3, a TRH-analog, reverses memory disruption by stimulating cholinergic and noradrenergic systems | Q49132405 | ||
| Association between dementia and elevated TSH: a community-based study. | Q50996052 | ||
| Thyroid function, depressed mood, and cognitive performance in older individuals: the Maastricht Aging Study. | Q50999429 | ||
| Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment. | Q51559362 | ||
| Is subclinical thyroid dysfunction in the elderly associated with depression or cognitive dysfunction? | Q51911425 | ||
| Dementia and low testosterone and bioavailable testosterone levels in men: possible increased risk. | Q51913538 | ||
| The significance of thyroid-stimulating hormone and homocysteine in the development of Alzheimer's disease in mild cognitive impairment: a 6-year follow-up study. | Q51914328 | ||
| Dementia and Alzheimer's disease incidence in relationship to cardiovascular disease in the Cardiovascular Health Study cohort. | Q51926808 | ||
| Prevalence of cognitive dysfunction and hypothyroidism in an elderly community population. | Q52011595 | ||
| The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study | Q52331318 | ||
| Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons | Q57073357 | ||
| NEUROPSYCHOLOGICAL TEST PERFORMANCE IN FRAMINGHAM: A DESCRIPTIVE STUDY | Q57746312 | ||
| Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study | Q57782109 | ||
| The investigation of dementia: results in 200 consecutive admissions | Q72464427 | ||
| Thyroid hormone regulates NGF content and p75LNGFR expression in the basal forebrain of adult rats | Q73123578 | ||
| Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study | Q73462518 | ||
| Thyroid dysfunction in patients with amyloid goitre | Q73634673 | ||
| “Mini-mental state” | Q25938989 | ||
| Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease | Q27860795 | ||
| Subclinical thyroid disease: scientific review and guidelines for diagnosis and management | Q28238612 | ||
| American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of hyperthyroidism and hypothyroidism | Q28272600 | ||
| The lifetime risk of stroke: estimates from the Framingham Study | Q33231050 | ||
| The effect of thyroid hormone on skeletal integrity | Q33652086 | ||
| Aggregation of vascular risk factors and risk of incident Alzheimer disease | Q33989502 | ||
| Thyroid disease and the heart | Q34038011 | ||
| Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease | Q34182395 | ||
| Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology | Q34244675 | ||
| Thyroid status, cardiovascular risk, and mortality in older adults | Q34421169 | ||
| Plasma cortisol and progression of dementia in subjects with Alzheimer-type dementia | Q35607536 | ||
| Thyroid disease in the elderly: sex-related differences in clinical expression. | Q36499855 | ||
| Insulin resistance syndrome and Alzheimer disease: pathophysiologic mechanisms and therapeutic implications | Q36667507 | ||
| Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. | Q38440090 | ||
| Subclinical hypothyroidism in a biethnic, urban community | Q39510306 | ||
| Thyroid hormone regulates endogenous amyloid-beta precursor protein gene expression and processing in both in vitro and in vivo models | Q40188127 | ||
| Reversible dementia. Illustrative cases, definition, and review | Q40283330 | ||
| Endocrine modulators of necrotic neuron death | Q41244564 | ||
| Thyroid hormone negatively regulates the transcriptional activity of the beta-amyloid precursor protein gene | Q42463601 | ||
| Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study | Q43745118 | ||
| Low serum thyrotropin (thyroid-stimulating hormone) in older persons without hyperthyroidism | Q43828967 | ||
| Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial | Q44456433 | ||
| Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease | Q44927343 | ||
| Increased cerebrospinal fluid levels of 3,3',5'-triiodothyronine in patients with Alzheimer's disease | Q45105933 | ||
| Thyroid status, disability and cognitive function, and survival in old age. | Q45168944 | ||
| P433 | issue | 14 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 1514-1520 | |
| P577 | publication date | 2008-07-01 | |
| P1433 | published in | JAMA Internal Medicine | Q177428 |
| P1476 | title | Thyroid function and the risk of Alzheimer disease: the Framingham Study | |
| P478 | volume | 168 |
| Q37222370 | A clinical review of the association of thyroid stimulating hormone and cognitive impairment |
| Q37210374 | A cross-sectional study on thyroid status in North Indian elderly outpatients with dementia |
| Q34484531 | Cardiovascular risk factors and future risk of Alzheimer's disease |
| Q36524879 | Changes of subtests of Wechsler Memory Scale and cognitive function in subjects with subclinical hypothyroidism following treatment with levothyroxine. |
| Q33752058 | Circulating biomarkers that predict incident dementia |
| Q34367086 | Clinical review: The thyroid in mind: cognitive function and low thyrotropin in older people |
| Q36824832 | Correlation of thyroid dysfunction and cognitive impairments induced by subcortical ischemic vascular disease |
| Q90117126 | Development of a Korean Hyperthyroidism-Specific Health Status Scale |
| Q35189725 | Differences in verbal memory performance in postmenopausal women receiving hormone therapy: 17β-estradiol versus conjugated equine estrogens |
| Q46989491 | Early-onset Alzheimer's disease: a global cross-sectional analysis. |
| Q26749493 | Endocrine Risk Factors for Cognitive Impairment |
| Q34574924 | Endocrine, metabolic, nutritional, and toxic disorders leading to dementia |
| Q34402261 | Follow-up of loci from the International Genomics of Alzheimer's Disease Project identifies TRIP4 as a novel susceptibility gene |
| Q35743051 | Functional status of thyroid and cognitive functions after menopause |
| Q62666878 | Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing |
| Q36618909 | Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individuals |
| Q62774672 | Geschlechtsspezifische Unterschiede der Endokrinologie im Alter |
| Q36112400 | Higher FT4 or TSH below the normal range are associated with increased risk of dementia: a meta-analysis of 11 studies |
| Q24613799 | Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses |
| Q90729561 | Hypothyroidism and Cognitive Disorders during Development and Adulthood: Implications in the Central Nervous System |
| Q34060003 | Hypothyroidism and risk of mild cognitive impairment in elderly persons: a population-based study |
| Q30235120 | Hypothyroidism. |
| Q34436072 | Imaging proteomics for diagnosis, monitoring and prediction of Alzheimer's disease |
| Q97526828 | Interactive Effects of Apolipoprotein E ε4 and Triiodothyronine on Memory Performance in Patients With Subjective Cognitive Decline |
| Q35929441 | Is thyroid status associated with cognitive impairment in elderly patients in China? |
| Q42427735 | Low levels of triiodothyronine in patients with Alzheimer's disease. |
| Q36302335 | Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology |
| Q37902373 | Non-psychiatric comorbidity associated with Alzheimer's disease. |
| Q64060795 | Overt and Subclinical Hypothyroidism in the Elderly: When to Treat? |
| Q90069269 | Prevalence and Risk Factors of Thyroid Dysfunction in Older Adults in the Community |
| Q35485670 | Relation of left ventricular ejection fraction to cognitive aging (from the Framingham Heart Study) |
| Q51015760 | Serum thyroid-stimulating hormone as a predictor of cognitive impairment in an elderly cohort. |
| Q34541613 | Subclinical Thyroid Dysfunction and the Risk of Cognitive Decline: a Meta-Analysis of Prospective Cohort Studies. |
| Q33591840 | Subclinical hyperthyroidism and dementia: the Sao Paulo Ageing & Health Study (SPAH). |
| Q26996108 | Subclinical hypothyroidism, mood, and cognition in older adults: a review |
| Q26852722 | Subclinical hypothyroidism: Controversies to consensus |
| Q83315660 | Subclinical thyroid disease |
| Q61456111 | TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone |
| Q36261211 | The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. |
| Q37137328 | The association of thyroid stimulating hormone levels with cognitive function and depressed mood: the Rancho Bernardo study |
| Q36069897 | The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study |
| Q37278592 | The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases |
| Q39533018 | Thyroid Function Variations Within the Reference Range Do Not Affect Quality of Life, Mood, or Cognitive Function in Community-Dwelling Older Men. |
| Q34168826 | Thyroid Hormones Are Associated with Poorer Cognition in Mild Cognitive Impairment |
| Q64245016 | Thyroid disorders in Brazil: the contribution of the Brazilian Longitudinal Study of Adult Health (ELSA-Brasil) |
| Q35096822 | Thyroid function in the euthyroid range and adverse outcomes in older adults |
| Q90257360 | Thyroid function tests before prescribing anti-dementia drugs: a retrospective observational study |
| Q37071245 | Thyroid hormones are associated with cognitive function: moderation by sex, race, and depressive symptoms |
| Q30668962 | Thyroid hormones are associated with longitudinal cognitive change in an urban adult population |
| Q33645788 | Thyroid medication use and subsequent development of dementia of the Alzheimer type |
| Q34497552 | Thyroid stimulating hormone, cognitive impairment and depression in an older korean population |
| Q38327396 | Thyrotropin and Alzheimer's Disease Risk in the Elderly: a Systematic Review and Meta-Analysis |
| Q50136568 | Treated hypothyroidism is associated with cerebrovascular disease but not Alzheimer's disease pathology in older adults. |
Search more.